Physician profile
Katrina Michalik
NPI 1629759543
$3,896.74
in general payments reported to CMS, 2019-2025
18 companies · $999 in 2025
The $999 reported for 2025 was more than what 87% of Acute Care (Clinical Nurse Specialist) providers received nationally (typical 2025 total: $137).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $139 · 2024: $2,759 · 2025: $999.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,688 · Travel and Lodging: $1,209.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,688.16 |
| Travel and Lodging | $1,208.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,208.58 | 2024 | |
| Astrazeneca Pharmaceuticals Lp | $506.35 | 2024-2025 | Lynparza |
| E.R. Squibb & Sons, L.L.C. | $501.34 | 2024-2025 | Opdivo, Reblozyl |
| Glaxosmithkline, LLC. | $419.08 | 2023-2025 | Jemperli, Zejula |
| Exelixis INC. | $235.57 | 2024-2025 | Cabometyx |
| Taiho Oncology, INC. | $191.30 | 2024 | |
| Eisai INC. | $168.84 | 2023-2025 | |
| Genmab U.S., INC. | $136.14 | 2023-2024 | Epkinly, Tivdak |
| Regeneron Healthcare Solutions, INC. | $124.99 | 2024 | Libtayo |
| Merck Sharp & Dohme LLC | $101.77 | 2024-2025 | Lynparza, Keytruda, Keytruda Qlex |
| Syndax Pharmaceuticals, INC. | $83.79 | 2025 | Revuforj |
| Abbvie INC. | $81.68 | 2024-2025 | |
| Myriad Genetic Laboratories, INC. | $44.25 | 2023-2024 | Myrisk |
| Ethicon US, LLC | $22.57 | 2024 | Stratafix |
| Novartis Pharmaceuticals Corporation | $21.76 | 2023 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acera Surgical, INC. | $20.69 | 2025 | Restrata Wound Matrix |
| Pfizer INC. | $14.71 | 2023 | |
| Immunogen, INC. | $13.33 | 2024 | Elahere |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katrina Michalik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.